1 / 6

Liquid Biopsy Market Size 2021 Covid-19 Analysis Insights by Size, Growth

Liquid Biopsy Market Size 2021 Covid-19 Analysis Insights by Size, Growth

19651
Download Presentation

Liquid Biopsy Market Size 2021 Covid-19 Analysis Insights by Size, Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liquid Biopsy Market Global Industry Survey, Growth, Competitive Landscape and Forecasts to2027 CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Liquid Biopsy Market Global Research Report - Forecast till 2027 Market Scope Market Research Future (MRFR) evaluates the Liquid Biopsy Market Size growth rate to be a healthy 28.0% between 2020 and 2027. Additionally, it is quite likely that the liquid biopsy market will touch USD 17,372.28 million by 2027-end, adds MRFR in its new study. Major Boosters and Impediments Liquid biopsy is a rapidly growing alternative for traditional tumor biopsies, stemming out of the urgent need for achieving maximum level of molecular information regarding cancer with minimum surgical invasion. With fast-paced innovations in NGS technology, liquid biopsies are touted to secure a major position in relation to cancer, in context of investigation and probe. Therapy and monitoring selection of breast cancer will remain the prime application of liquid biopsy in the years ahead. With that said, over the next few years, following the validation provided by rigorous clinical trials, liquid biopsy can emerge as the leading method of diagnosis for different types of cancers, such as pancreatic cancers and CNS. Apart from this, the surging demand for noninvasive procedures, as well as increasing spending on R&D based on liquid biopsy can further auger the market position. Various established and small companies in the global market are collaborating or are entering long-term agreements, to elevate their rankings. Increase in joint ventures to pool in sufficient funds and combined expertise for carrying out exhaustive research activities should favor the global industry to a large extent. To illustrate, in April 2021, OncoDNA partnered with Institut to study the liquid biopsy-based treatment technique for patients with neck and head cancer. This partnership will be combining OncoDNA's blood based NGS test, OncoFollow, with Institut Curie's biobanking SCANDARE analysis. SCANDARE researchers will administer the OncoFollow tests to individuals at varying levels of treatment, to monitor their disease progression while also guiding treatment selection in case new mutations develop 2 www.marketresearchfuture.com

  3. Liquid Biopsy Market Global Research Report - Forecast till 2027 Market Segmentation Market Research Future report offers an all-inclusive segmental analysis of the liquid biopsy market on the basis of biomarker type, application, sample and end-users Based on biomarker type, it is segmented into extracellular vesicles (Evs), circulating tumor DNA (Ctdna), circulating tumor cells (Ctcs) and others. Of these, circulating tumor cells (CTCs) will have the largest share in the liquid biopsy market with regards to both revenues and market share. Based on application, the liquid biopsy market is segmented into reproductive health, cancer therapeutic application and other forms of therapeutic application. Of these, cancer therapeutic application will dominate the market over the forecast period. Based on sample, it is segmented into urine, blood and others. Based on end-users, the liquid biopsy market is segmented into academic and research centres, hospitals and laboratories and others. ReportDetails @https://www.marketresearchfuture.com/sample_request/710 • 3 www.marketresearchfuture.com

  4. Liquid Biopsy Market Global Research Report - Forecast till 2027 Regional Status The liquid biopsy market is geographically split into Europe, North America, MEA/Middle East & Africa as well as Asia Pacific/APAC. In 2016, the highest share of 37.95% in the global market was seized by North America and since then, the region has been charting a relentless upward trajectory backed by the alarming increase in cancer cases. This has fostered the need for effective screening while enhancing the competition level between biotech companies. Many players in the region are striving to enter regions with untapped potential. Apart from this, government funding to research institutes to either develop or upgrade the existing liquid biopsy testing techniques will facilitate further market expansion in the coming years. The European market will capture a noteworthy growth rate of 28.5% from 2020 to 2027, considering the large-scale investments on clinical trials proving the effectivity and exploring new applications of liquid biopsy. More and more companies are foraying into the liquid biopsy industry, sensing the host of opportunities and growth potential. Various companies in Europe are adopting inorganic strategies like collaboration, partnerships, and agreements, while also teaming up with cancer centers and universities to gain strong expertise. The fastest growth rate of 29.7% will be procured by the APAC market, in view of the rising efforts of companies as well as governments to contain the escalating prevalence of cancer cases in the region. India, Japan, and China are the highest contributors in the regional market, thanks to the heightened preference for non-invasive treatment, and the advances in the healthcare infrastructure of these countries Get Request FreeSample Copy Available@ https://www.marketresearchfuture.com/reports/liquid-biopsy- market-710 4 www.marketresearchfuture.com

  5. Liquid Biopsy Market Global Research Report - Forecast till 2027 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous- Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry expertsand industrial visits forits research analyst members. For more information kindly visit www.marketresearchfuture.com or contact usat info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. 5 www.marketresearchfuture.com

  6. THANK YOU salesteam@marketresearchfuture.com Ph: +1-646-845-9349(US) Ph: +44 208 133 9349 (UK)

More Related